Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Breast Neoplasms and CYP2A6[original query] |
---|
Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women. European journal of clinical pharmacology 2011 Oct 67 (10): 1017-25. Tanii Hiromi, Shitara Yoshihisa, Horie Toshiha |
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age. Clinical pharmacology and therapeutics 2011 Nov 90 (5): 693-700. Desta Z, Kreutz Y, Nguyen A T, Li L, Skaar T, Kamdem L K, Henry N L, Hayes D F, Storniolo A M, Stearns V, Hoffmann E, Tyndale R F, Flockhart D |
The pharmacokinetics of letrozole: association with key body mass metrics. International journal of clinical pharmacology and therapeutics 2012 Aug 50 (8): 557-65. Jin Seok-Joon, Jung Jin Ah, Cho Sang-Heon, Kim Un-Jib, Choe Sangmin, Ghim Jong-Lyul, Noh Yook-Hwan, Park Hyun-Jung, Kim Jung-Chul, Jung Jin-A, Lim Hyeong-Seok, Bae Kyun-Se |
Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers. Current drug metabolism 2015 16 (10): 850-63. He Xin, Feng Sh |
Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of Breast Cancer. International journal of molecular sciences 2016 Oct 17 (10): . Verde Zoraida, Santiago Catalina, Chicharro Luis Miguel, Reinoso-Barbero Luis, Tejerina Alejandro, Bandrés Fernando, Gómez-Gallego Fél |
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer. Breast cancer research and treatment 2018 8 172 (2): 371-379. Borrie Adrienne E, Rose Rhiannon V, Choi Yun-Hee, Perera Francisco E, Read Nancy, Sexton Tracy, Lock Michael, Vandenberg Theodore A, Hahn Karin, Dinniwell Robert, Younus Jawaid, Logan Diane, Potvin Kylea, Yaremko Brian, Yu Edward, Lenehan John, Welch Stephen, Tyndale Rachel F, Teft Wendy A, Kim Richard |
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.
Pharmacogenetics and genomics 2021 Jul 31 (5): 116-123. Hertz Daniel L, Douglas Julie A, Kidwell Kelley M, Gersch Christina L, Desta Zeruesenay, Storniolo Ana-Maria, Stearns Vered, Skaar Todd C, Hayes Daniel F, Henry N Lynn, Rae James |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: